Such a finding is in good agreement with data obtained under inhibition of T cell tumor infiltration by fingolimod, a sphingosine-1-phosphate receptor modulator, which significantly diminished the IAV in tumor growth patterns under both no treatment and treatment conditions [13]. Here, S1PR1 is linked to neoplasm.